S100B and its association with HIV-associated neurocognitive disorders
J Neurovirol
.
2019 Dec;25(6):899-900.
doi: 10.1007/s13365-019-00773-8.
Epub 2019 Jul 5.
Authors
Nath Limpruttidham
1
2
,
Brooks I Mitchell
3
,
Kalpana J Kallianpur
3
,
Beau K Nakamoto
3
4
,
Scott A Souza
3
5
,
Bruce Shiramizu
3
,
Lishomwa C Ndhlovu
3
6
,
Dominic C Chow
3
,
Cecilia M Shikuma
3
Affiliations
1
Hawaii Center for AIDS, Department of Medicine, University of Hawaii John A. Burns School of Medicine, Honolulu, HI, USA. nlimprut@hawaii.edu.
2
University of Hawaii Internal Medicine Residency, Honolulu, HI, USA. nlimprut@hawaii.edu.
3
Hawaii Center for AIDS, Department of Medicine, University of Hawaii John A. Burns School of Medicine, Honolulu, HI, USA.
4
Straub Hospital, Honolulu, HI, USA.
5
The Queen's Medical Center, Honolulu, HI, USA.
6
Department of Tropical Medicine, Medical Microbiology & Pharmacology, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI, USA.
PMID:
31278533
DOI:
10.1007/s13365-019-00773-8
No abstract available
Publication types
Letter
Comment
MeSH terms
Biomarkers
HIV Infections*
Humans
Neurocognitive Disorders
S100 Calcium Binding Protein beta Subunit
Uganda
Substances
Biomarkers
S100 Calcium Binding Protein beta Subunit
S100B protein, human
Grants and funding
R01 HL095135/HL/NHLBI NIH HHS/United States